THE EFFECTS OF HYPERTENSION TREATMENTS IN QUALITY OF LIFE OF PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS IN RSUP DR. HASAN SADIKIN BANDUNG
Hypertension is the leading cause of chronic kidney disease (CKD) through a process that resulted in loss a largenumber of functional nephron on progressive and irreversible. Decreation of blood pressure is goal therapy of chronic kidney disease. The Kidney Disease Outcome Quality Initiative (K/DOQI...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/78990 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |
| Summary: | Hypertension is the leading cause of chronic kidney disease (CKD) through a process that resulted in loss a largenumber of functional nephron on progressive and irreversible. Decreation of blood pressure is goal therapy of chronic kidney disease. The Kidney Disease Outcome Quality Initiative (K/DOQI) of the national kidney foundation (NKF) recommends a target blood pressure values of < 130/80 mmHg in CKD patients, it can be reduce the risk of cardiovascular disease. The purpose of this study is to understand of the antihypertension medication effects to the quality of life hemodialysis patients in RSUP DR.Hasan Sadikin Bandung. The design of study is cross sectional observational with concurrent medical record with patients daily status analyses during December 2015 Februamy 2016 with questionnaire health related quality of life as measured by the Kidney Disease and Quality of Life (KDQOL-36. The objects this study is hemodialysis patients and receive antihypertension medication, man and women, more than 18 years Old. The analysis result shows significant differences in the reduction of systolic (p=0,011) and diastolic (p=0,023) blood pressure in each group of antihypertension therapy. Furthermore, 2 combination of antihypertension therapy gives the most significant different in reduction of systolic and diastolic blood pressure (p—0,001). Second combination of antihypertension therapy can be reduce of blood pressure better than 3 combinations therapy. For each variosly of hypertension therapy, there is no significant difference was observed against quality of life. In summary, second combinations of antihypertension therapy is best for decrease of blood pressure and creatinin serum. In all domain of quality of lifes, symptom/problems have a highest score, and burden of kidney disease have a lowest score of quality of life.
|
|---|